A detailed history of Cutler Group LP transactions in Twist Bioscience Corp stock. As of the latest transaction made, Cutler Group LP holds 1,700 shares of TWST stock, worth $83,130. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,700
Holding current value
$83,130
% of portfolio
0.02%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$32.28 - $41.5 $54,876 - $70,550
1,700 New
1,700 $58,000
Q3 2023

Nov 07, 2023

BUY
$18.62 - $26.57 $5,586 - $7,971
300 New
300 $6,000
Q1 2022

Apr 14, 2022

BUY
$38.58 - $83.27 $3,858 - $8,327
100 Added 25.0%
500 $24,000
Q4 2021

Jan 18, 2022

BUY
$75.47 - $135.88 $7,547 - $13,588
100 Added 33.33%
400 $30,000
Q3 2021

Oct 26, 2021

SELL
$95.64 - $131.48 $9,564 - $13,147
-100 Reduced 25.0%
300 $32,000
Q2 2021

Jul 19, 2021

SELL
$88.13 - $142.06 $36,926 - $59,523
-419 Reduced 51.16%
400 $53,000
Q1 2021

Apr 26, 2021

BUY
$105.48 - $207.97 $86,388 - $170,327
819 New
819 $101,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.76B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.